Divis Laboratories Ltd
NSE: DIVISLAB BSE: 532488
₹5952.50
(-1.71)%
Mon, 02 Feb 2026, 11:00 pm
Market Cap1607.21B
PE Ratio63.59
Dividend0.50
Health Technology
Pharmaceuticals: Major
24.5KFinancials
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 3.81B | 7.25B | 10.33B | 11.80B | 9.42B | 13.07B | 18.59B | 21.40B | 25.25B | 31.03B | 37.74B | 40.62B | 38.26B | 48.29B | 53.08B | 68.82B | 89.06B | 77.49B | 78.32B | 93.58B |
| Gross profit | 1.12B | 2.30B | 3.96B | 4.86B | 4.12B | 5.46B | 7.35B | 8.54B | 10.48B | 11.76B | 14.74B | 15.83B | 13.14B | 18.67B | 19.05B | 29.24B | 39.86B | 25.54B | 24.13B | 31.91B |
| Operating expenses (excl. COGS) | -25.05M | -33.22M | -3.25M | -67.00M | -547.30M | -1.08B | -1.11B | -1.20B | -1.30B | -1.50B | -1.62B | -2.03B | -2.36B | -2.17B | -2.97B | -3.63B | -4.25B | -4.91B | -4.61B | -5.53B |
| Selling/general/admin expenses, total | — | — | — | — | -548.95M | -1.08B | -1.09B | -1.17B | -1.25B | -1.44B | -1.56B | -1.95B | -2.30B | -2.09B | -2.84B | -3.50B | -4.08B | -4.76B | -4.44B | -5.32B |
| Research & development | -87.19M | -102.80M | -111.32M | -119.65M | -112.83M | -159.81M | -188.59M | -239.99M | -253.91M | -276.62M | -309.24M | -431.20M | -317.70M | -348.90M | -382.30M | -510.10M | -549.50M | -693.40M | -790.00M | -800.00M |
| Selling/general/admin expenses, other | — | — | — | — | -436.12M | -920.11M | -904.25M | -930.67M | -992.14M | -1.17B | -1.25B | -1.52B | -1.98B | -1.74B | -2.46B | -2.99B | -3.53B | -4.07B | -3.65B | -4.52B |
| Other operating expenses, total | -25.05M | -33.22M | -3.25M | -67.00M | 1.65M | 0 | -15.13M | -32.81M | -49.91M | -60.12M | -61.34M | -76.10M | -58.90M | -85.30M | -125.10M | -124.70M | -169.00M | -149.70M | -170.00M | -210.00M |
| Operating income | 1.01B | 2.16B | 3.84B | 4.67B | 3.57B | 4.38B | 6.24B | 7.34B | 9.19B | 10.26B | 13.12B | 13.80B | 10.78B | 16.49B | 16.09B | 25.61B | 35.62B | 20.62B | 19.52B | 26.38B |
| Non-operating income, total | 43.03M | 29.05M | -69.91M | -188.32M | 284.57M | 339.95M | 564.77M | 471.89M | 723.58M | 463.25M | 778.83M | 149.70M | 1.53B | 2.06B | 2.11B | 1.05B | 1.22B | 3.06B | 2.11B | 2.78B |
| Interest expense, net of interest capitalized | -43.40M | -88.78M | -82.05M | -40.10M | -11.90M | -6.63M | -23.93M | -15.18M | -15.07M | -28.55M | -43.90M | -21.70M | -23.50M | -28.50M | -71.30M | -20.90M | -19.90M | -19.60M | -20.00M | -30.00M |
| Interest capitalized | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | 88.56M | 117.83M | 12.13M | -148.23M | 297.52M | 349.47M | 599.18M | 494.29M | 763.32M | 550.10M | 855.20M | 159.70M | 1.53B | 1.78B | 1.73B | 1.07B | 1.24B | 3.08B | 2.08B | 2.80B |
| Non-operating interest income | 6.10M | 4.65M | 9.20M | 8.65M | 6.36M | 12.05M | 7.00M | 27.27M | 60.98M | 46.46M | 97.12M | 54.80M | 43.50M | 74.80M | 66.60M | 572.40M | 689.60M | 2.05B | 3.01B | 2.95B |
| Miscellaneous non-operating expense | 82.46M | 113.18M | 2.94M | -156.88M | 291.16M | 337.42M | 592.18M | 467.02M | 702.34M | 503.64M | 758.07M | 104.90M | 1.48B | 1.70B | 1.66B | 499.50M | 547.40M | 1.04B | -930.00M | -150.00M |
| Unusual income/expense | -2.13M | — | — | — | -1.05M | -2.89M | -10.48M | -7.21M | -24.67M | -58.30M | -32.47M | 11.70M | 26.30M | 306.80M | 449.90M | 0 | 0 | 0 | 50.00M | 10.00M |
| Pretax income | 1.06B | 2.19B | 3.77B | 4.48B | 3.85B | 4.72B | 6.81B | 7.81B | 9.91B | 10.72B | 13.93B | 13.95B | 12.31B | 18.55B | 18.19B | 26.66B | 36.84B | 23.69B | 21.63B | 29.16B |
| Taxes | -359.98M | -331.13M | -295.78M | -313.71M | -449.91M | -431.05M | -1.47B | -1.79B | -2.18B | -2.21B | -2.67B | -3.35B | -3.54B | -5.02B | -4.43B | -6.82B | -7.23B | -5.45B | -5.63B | -7.25B |
| Non-controlling/minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| After tax other income/expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | 695.34M | 1.86B | 3.48B | 4.17B | 3.40B | 4.29B | 5.33B | 6.02B | 7.73B | 8.52B | 11.26B | 10.60B | 8.77B | 13.53B | 13.77B | 19.84B | 29.60B | 18.23B | 16.00B | 21.91B |
| Net income | 695.34M | 1.86B | 3.48B | 4.17B | 3.40B | 4.29B | 5.33B | 6.02B | 7.73B | 8.52B | 11.26B | 10.60B | 8.77B | 13.53B | 13.77B | 19.84B | 29.60B | 18.23B | 16.00B | 21.91B |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | 695.34M | 1.86B | 3.48B | 4.17B | 3.40B | 4.29B | 5.33B | 6.02B | 7.73B | 8.52B | 11.26B | 10.60B | 8.77B | 13.53B | 13.77B | 19.84B | 29.60B | 18.23B | 16.00B | 21.91B |
| Basic earnings per share (Basic EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA | 1.16B | 2.38B | 4.20B | 5.15B | 4.08B | 4.92B | 6.86B | 8.11B | 10.11B | 11.62B | 14.30B | 15.04B | 12.21B | 18.18B | 17.95B | 28.16B | 38.73B | 24.05B | 23.30B | 30.40B |
| EBIT | 1.01B | 2.16B | 3.84B | 4.67B | 3.57B | 4.38B | 6.24B | 7.34B | 9.19B | 10.26B | 13.12B | 13.80B | 10.78B | 16.49B | 16.09B | 25.61B | 35.62B | 20.62B | 19.52B | 26.38B |
| Total operating expenses | -2.80B | -5.09B | -6.49B | -7.13B | -5.85B | -8.69B | -12.34B | -14.06B | -16.07B | -20.77B | -24.63B | -26.82B | -27.48B | -31.80B | -36.99B | -43.22B | -53.44B | -56.87B | -58.80B | -67.20B |
| Prepaid expenses | 74.24M | 18.99M | 17.88M | 104.34M | 241.04M | 134.34M | 40.08M | 30.63M | 35.81M | 56.80M | 185.87M | 57.50M | 62.20M | 91.90M | 169.70M | 225.00M | 270.90M | 272.00M | 640.00M | 370.00M |
| Deferred income, current | — | — | — | — | — | — | — | — | 128.52M | 406.27M | 397.77M | 305.90M | 395.30M | 290.80M | 293.40M | 160.60M | 166.30M | 327.20M | 340.00M | 400.00M |
| Capital and operating lease obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 44.70M | 36.90M | 28.70M | 27.70M | 20.00M | 20.00M |
| Operating lease liabilities | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Deferred tax liabilities | 287.63M | 302.69M | 424.68M | 497.21M | 545.66M | 589.80M | 697.26M | 894.46M | 1.25B | 1.37B | 772.72M | 1.26B | 1.93B | 2.21B | 2.74B | 3.51B | 4.43B | 5.54B | 6.02B | 5.24B |
| Deferred income, non-current | 0 | 0 | 0 | 0 | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | — | — | — | — | — | — |
| Minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in accrued expenses | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 64.50M | 82.70M | 60.00M | 70.00M |
| Common dividends paid | -102.55M | -257.30M | 0 | -258.69M | -455.21M | -924.55M | -1.54B | -2.01B | -2.33B | -3.11B | -6.39B | 0 | -3.19B | -3.20B | -10.24B | 0 | -5.31B | -7.96B | -7.96B | -7.96B |
| Preferred dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800